These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 3316312

  • 1. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [Abstract] [Full Text] [Related]

  • 2. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE, Biggs J, Jacobs M, Holden K.
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA, Keller FD, Buchanan RA, Gibson RE, Fleming JA.
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [Abstract] [Full Text] [Related]

  • 4. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.
    Drug Alcohol Depend; 2005 Nov 01; 80(2):209-21. PubMed ID: 15913920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan 01; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 01; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 9. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP, Merideth CH, Claghorn JL.
    J Clin Psychiatry; 1984 Apr 01; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [Abstract] [Full Text] [Related]

  • 10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, Sayler M.
    J Clin Psychopharmacol; 1993 Oct 01; 13(5):305-11. PubMed ID: 8227488
    [Abstract] [Full Text] [Related]

  • 12. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MG.
    Psychooncology; 1998 Oct 01; 7(4):291-300. PubMed ID: 9741068
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J, Kiev A, Fabre LF.
    Depress Anxiety; 1999 Oct 01; 9(2):54-60. PubMed ID: 10207659
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J, Barkin RL.
    J Clin Psychiatry; 1998 Mar 01; 59(3):123-7. PubMed ID: 9541155
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec 01; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 17. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar 01; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
    Pecknold J, Luthe L, Munjack D, Alexander P.
    J Clin Psychopharmacol; 1994 Oct 01; 14(5):314-21. PubMed ID: 7806686
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.